Moxonidin Actavis (Moxonidine)

Moxonidine is indicated for the management of hypertension, acting on central sympathetic pathways to reduce blood pressure.

• Essential hypertension: helps achieve target blood‑pressure goals in patients with primary hypertension.
• Resistant hypertension: provides additional blood‑pressure control when other agents are insufficient.
• Elevated systolic blood pressure: lowers systolic readings in adults with high systolic values.

• Moxonidine selectively stimulates central imidazoline I1 receptors, which diminishes sympathetic outflow from the brainstem. This reduction in sympathetic activity leads to decreased peripheral vascular resistance and lower cardiac output, resulting in a modest but consistent reduction in arterial blood pressure.

Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Dry mouth: sensation of oral dryness.
• Fatigue: feeling of tiredness or lack of energy.
• Dizziness: light‑headedness, especially when standing quickly.
• Headache: mild to moderate head pain.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure requiring medical attention.
• Bradycardia: unusually slow heart rate.
• Allergic reaction: rash, itching, swelling, or difficulty breathing.
• Liver enzyme elevation: abnormal liver function tests.
• Depression: new or worsening mood symptoms.
• Cardiac arrhythmia: irregular heart rhythm.

Before initiating therapy, consider the following safety measures.

• Blood pressure monitoring: check BP regularly to assess response and avoid excessive lowering.
• Renal impairment: adjust dose or monitor closely in patients with reduced kidney function.
• Diabetes mellitus: watch for changes in glucose control as sympathetic tone influences insulin sensitivity.
• Abrupt discontinuation: taper the dose to prevent rebound hypertension.
• Elderly patients: start at the lowest effective dose and monitor for dizziness.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Moxonidine can interact with other medicines that affect blood pressure or sympathetic activity.

Major Interactions (Avoid)

• Other central antihypertensives (e.g., clonidine): additive hypotensive effect may cause severe low BP.
• ACE inhibitors or ARBs combined with diuretics: risk of excessive blood‑pressure reduction.

Moderate Interactions (Monitor Closely)

• Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive response.
• Alcohol: can enhance dizziness and hypotension.
• Lithium: possible increase in lithium levels; monitor serum concentrations.